Bvf Partners L P/Il

EDGAR CIK 0001055947

Kymera Therapeutics, Inc. - KYMR

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director Other owner
Direct Buys
0
$0
0 Shares
Direct Sells
1
($168.14) M
-1,578,800 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
1
($5.52) M
-51,858 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
06/26/2026
06/26/2026
Sell
-1,578,800 @ $106.50
 ($168,142,200) 240,123 (-86.80%) Direct
06/26/2026
06/26/2026
Sell
-51,858 @ $106.50
 ($5,522,877) 78,787 (-39.69%) Indirect - See footnote

MoonLake Immunotherapeutics - MLTX

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
1
($62.96) M
-3,750,000 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/31/2026
04/02/2026
Sell
-3,750,000 @ $16.79
 ($62,962,500) 1,039,238 (-78.30%) Direct